Prospective Quality of Life Research in Bony Metastatic Disease

Clinical Orthopaedics and Related Research

Volumn 415, Issue SUPPL., 2003, Pages

  Cheng, Edward Y ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE;

AGED; ANALGESIA; BONE METASTASIS; CANCER; CONFERENCE PAPER; FEMALE; FRACTURE; FUNCTIONAL ASSESSMENT; HUMAN; OSTEOSYNTHESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMETRY; QUALITY OF LIFE; RISK BENEFIT ANALYSIS;

EID: 0142157058     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000093054.96273.20     Document Type: Conference Paper

References (35)

1. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993.
2. Broos P, Reynders P, van den Bogert W, Vanderschot P: Surgical treatment of metastatic fracture of the femur improvement of quality of life. Acta Orthop Belg 59:52-56, 1993.
3. Broos PL, Rommens PM, Vanlangenaker MJ: Pathological fractures of the femur: Improvement of quality of life after surgical treatment. Arch Orthop Trauma Surg 111:73-77, 1992.
4. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993.
5. Clinch JJ: The Functional Living Index-Cancer: Ten Years Later. In Spilker B (ed). Quality of Life and Pharmacoeconomics Clinical Trials. Philadelphia, Lippincott-Raven 215-225, 1996.
6. Clohisy DR, Le CT, Cheng EY, et al: Evaluation of the feasibility of and results of measuring health-status changes in patients undergoing surgical treatment for skeletal metastases. J Orthop Res 18:1-9, 2000.
7. Daut RL, Cleeland CS, Flanery RC: Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17:197-210, 1983.
8. Davis AM, Bell RS, Badley EM, et al: Evaluating functional outcome in patients with lower extremity sarcoma. Clin Orthop 358:90-100, 1999.
9. de Haes JC, Raatgever JW, van der Burg ME, et al: Evaluation of the quality of life of patients with advanced ovarian cancer treated with combination chemotherapy. Monograph Series of the European Organization for Research and Treatment of Cancer 17:215-226, 1987.
10. Enneking WF, Dunham W, Gebhardt MC, et al: A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 286:241-246, 1993.
11. Fishman B, Pasternak S, Wallenstein SL, et al: The Memorial Pain Assessment Card: A valid instrument for the evaluation of cancer pain. Cancer 60:1151-1158, 1987.
12. Gaze MN, Kelly CG, Kerr GR, et al: Pain relief and quality of life following radiotherapy for bone metastases: A randomised trial of two fractionation schedules. Radiother Oncol 45:109-116, 1997.
13. Gilbert HA, Kagan AR, Nussbaum H, et al: Evaluation of radiation therapy for bone metastases: Pain relief and quality of life. Am J Roentgenol 129:1095-1096, 1977.
14. Graham C, Bond SS, Gerkovich MM, Cook MR: Use of the McGill pain questionnaire in the assessment of cancer pain: Replicability and consistency. Pain 8:377-387, 1980.
15. Graupe F, Heitmann C, Becker M, et al: [Palliative surgical treatment of bone metastases. Improved quality of life by early intervention?]. Dtsch Med Wochenschr 121:393-397, 1996.
16. Nelson GR, Streiner DL: Biostatistics: The Bare Essentials. St Louis, Mosby 1994.
17. Nunnally JC: Psychometric Theory. New York, McGraw-Hill 1978.
18. Okuyama T, Korenaga D, Tamura S, et al: Quality of life following surgery for vertebral metastases from breast cancer. J Surg Oncol 70(Suppl):60-63, 1999.
19. Osoba D: Health-related quality-of-life assessment in clinical trials of supportive care in oncology. Support Care Cancer 8:84-88, 2000.
20. Popken F, Schmidt J, Oegur H, et al: [Treatment outcome after surgical management of osseous breast carcinoma metastases: Preventive stabilization vs. management after pathological fracture]. Unfallchirurg 105:338-343, 2002.
21. Porter AT, McEwan AJ, Powe JE, et al: Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 25:805-813, 1993.
22. Serlin RC, Mendoza TR, Nakamura Y, et al: When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277-284, 1995.
23. Sloan JA, Loprinzi CL, Kuross SA, et al: Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol 16:3662-3673, 1998.
24. Spitzer WO, Dobson AJ, Hall J, et al: Measuring the quality of life of cancer patients: A concise QL-index for use by physicians. J Chronic Dis 34:585-597, 198l.
25. Stead ML, Brown JM, Velikova G, et al: Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma: European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Br J Haematol 104:605-611, 1999.
26. Stockler MR, Osoba D, Corey P, et al: Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module: European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. J Clin Epidemiol 52:653-666, 1999.
27. Stockler MR, Osoba D, Goodwin P, et al: Responsiveness to change in health-related quality of life in a randomized clinical trial: A comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module: European Organization for Research and Treatment of Cancer. J Clin Epidemiol 51:137-145, 1998.
28. Tannock IF, Osoba D, Stockler MR, et al: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points. J Clin Oncol 14:1756-1764, 1996.
29. Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C: Observer error in grading performance status in cancer patients. Support Care Cancer 7:332-335, 1999.
30. Vitale G, Fonderico F, Martignetti A, et al: Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer 84:1586-1590, 2001.
31. Wang XS, Cleeland CS, Mendoza TR, et al: The effects of pain severity on health-related quality of life: A study of Chinese cancer patients. Cancer 86:1848-1855, 1999.
32. Ware Jr JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473-483, 1992.
33. Wedin R, Bauer HC, Rutqvist LE: Surgical treatment for skeletal breast cancer metastases: A population-based study of 641 patients. Cancer 92:257-262, 2001.
34. Wisloff F, Eika S, Hippe E, et al: Measurement of health-related quality of life in multiple myeloma: Nordic Myeloma Study Group. Br J Haematol 92:604-613, 1996.
35. Wisloff F, Gulbrandsen N: Health-related quality of life and patients' perceptions in interferon-treated multiple myeloma patients: Nordic Myeloma Study Group. Acta Oncol 39:809-813, 2000.